This project is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory track illness in infants. Pregnant women will be given a stabilized RSV prefusion F subunit vaccine or placebo during late 2nd trimester or early 3rd trimester of pregnancy. There will be infant follow-up for 24 months.
Prevent respiratory syncytial virus (RSV) disease by immunizing pregnant women
vNOTES is an innovative technique that inserts a device through the vagina to perform common procedures such as hysterectomies. The technique is used to replace laparoscopic surgery, an operation performed using small incisions through the abdomen or pelvis.
In an effort to help relieve patient concerns, USA Health’s Department of Obstetrics and Gynecology has added the Pediatric and Adolescent Gynecology Division.
